Pharma's Almanac’s Post

View organization page for Pharma's Almanac, graphic

5,352 followers

Touchlight's enzymatically amplified dbDNA™ (doggybone DNA) is redefining biomanufacturing with unparalleled speed, purity, scalability, and clinical adoption. In this exclusive article, Jill Makin, Chief Scientific Officer at Touchlight, shares insights on how this technology is setting new benchmarks in the field of genomic medicine. Read the full article here: https://lnkd.in/ezj9dXKv #CDMOExcellence #DNA #Biopharma #Innovation

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics